SCHEMBL29071349

SCHEMBL29071349

Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1cc(-c2cnc3c(N)ncnn23)cn1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 11/20 0.72
▸ BCR P11274 9/20 0.72
▸ BRAF P15056 3/20 0.58
▸ RAF1 P04049 1/20 0.58
▸ CYP2C9 P11712 1/20 0.51
▸ KIT P10721 5/20 0.50
▸ LCK P06239 4/20 0.50
▸ CSF1R P07333 3/20 0.50
▸ KDR P35968 3/20 0.50
▸ MAPK14 Q16539 3/20 0.50
▸ EPHB4 P54760 2/20 0.50
▸ BTK Q06187 1/20 0.50
▸ SRC P12931 2/20 0.48
▸ TEK Q02763 2/20 0.48
▸ FES P07332 1/20 0.48
▸ RET P07949 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ FGFR1 P11362 1/20 0.48
▸ PDGFRA P16234 1/20 0.48
▸ FLT1 P17948 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29921892 1.00 ABL1 (0.72) ABL1BCRBRAFRAF1CYP2C9
SCHEMBL29071524 0.94 ABL1 (0.63) ABL1BCRBRAFRAF1KIT
SCHEMBL29921279 0.94 ABL1 (0.63) ABL1BCRBRAFRAF1KIT
SCHEMBL29921869 0.92 ABL1 (0.60) ABL1BCRBRAFRAF1CYP2C9
SCHEMBL29071512 0.92 ABL1 (0.60) ABL1BCRBRAFRAF1CYP2C9
SCHEMBL29071312 0.91 ABL1 (0.61) ABL1BCRBRAFRAF1KIT
SCHEMBL29921674 0.91 ABL1 (0.59) ABL1BCRBRAFRAF1CYP2C9
SCHEMBL29071240 0.91 ABL1 (0.59) ABL1BCRBRAFRAF1CYP2C9
SCHEMBL29921977 0.91 ABL1 (0.61) ABL1BCRBRAFRAF1KIT
SCHEMBL29071269 0.90 ABL1 (0.59) ABL1BCRBRAFRAF1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761801-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-09-15 — — CN disclosed
Send feedback